DAX 30 Index Could Pullback on Recovery Fund Delay, AstraZeneca Shot Ban
DAX 30 Index Could Pullback on Recovery Fund Delay, AstraZeneca Shot Ban 2021-04-01 07:00:00 Daniel Moss, Analyst DAX 30, EU Recovery Fund, AstraZeneca Vaccine, Coronavirus Cases, Restrictions – Talking Points: Equity markets largely gained ground during APAC trade as investors mulled the prospect of additional US fiscal stimulus. The delayed ratification of the EU Recovery Fund and a ban on AstraZeneca’s vaccine may weigh on the German DAX 30 index in the near term. Asia-Pacific Recap Equity markets gained ground durin...
Source: dailyfx.com